Itrasys CF 100 Capsule contains Itraconazole 100 mg, a broad-spectrum triazole antifungal agent used for the treatment of various systemic and superficial fungal infections. Itraconazole works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting cell membrane integrity and leading to fungal cell death. This medication is indicated for the management of infections caused by susceptible strains of fungi, including aspergillosis, blastomycosis, histoplasmosis, and onychomycosis, as well as other dermatophytic infections. Itrasys CF 100 Capsule is administered orally and is absorbed better when taken with food, enhancing its bioavailability. It is important to adhere to the prescribed dosage and duration to ensure therapeutic efficacy and minimize the risk of resistance development. Caution is advised in patients with hepatic impairment, congestive heart failure, or those taking medications that may interact with itraconazole due to its potential to inhibit cytochrome P450 enzymes. Common adverse effects include gastrointestinal disturbances, headache, and rash. Regular monitoring of liver function tests is recommended during prolonged therapy. Itrasys CF 100 Capsule should be used under medical supervision to ensure safe and effective treatment of fungal infections.